Insider · CIK 0001865796
Sohanya Roshan Cheng
Files at CARM (Carisma Therapeutics Inc.), KPTI (Karyopharm Therapeutics Inc.). First filing Mar 4, 2024, latest May 15, 2026.
In brief
Sohanya Roshan Cheng files SEC Form 4 as director and officer at KPTI (Karyopharm Therapeutics Inc.), and also at CARM (Carisma Therapeutics Inc.). Since Mar 4, 2024, Sohanya Roshan Cheng has reported 0 open-market buys worth $0 and 5 open-market sells worth $102k, the latest filed on May 15, 2026.
A track record needs three past buys with six months of prices behind them; Sohanya Roshan Cheng has 0, so none is measured yet.
The newest scored trade: sold $3,078 of KPTI on May 14, 2026, filed May 15, 2026, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $46k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KPTI: Karyopharm Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Karyopharm Therapeutics Inc. | $3,078 324 shares | -0% | +136% from low-12% from high | |
| 36Weak | Karyopharm Therapeutics Inc. | $43k 4,604 shares | -4% | +171% from low-5% from high | |
| 30Weak | Karyopharm Therapeutics Inc. | $2,090 325 shares | -1% | +77% from low-58% from high | |
| 30Weak | Karyopharm Therapeutics Inc. | $22k 3,445 shares | -9% | - | |
| 35Weak | Karyopharm Therapeutics Inc. | $32k 26,949 shares | -6% | +72% from low-75% from high |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +947 | $0.00 | $0 | 108,264 | May 15, 2026 |
| May 14, 2026 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -324 | $9.50 | $3,078 | 107,940 | May 15, 2026 |
| Mar 2, 2026 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -4,604 | $9.41 | $43k | 107,317 | Mar 3, 2026 |
| Jan 31, 2026 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +32,415 | $0.00 | $0 | 111,921 | Feb 3, 2026 |
| Oct 15, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +43,650 | $0.00 | $0 | 79,506 | Oct 16, 2025 |
| Sep 12, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +945 | $0.00 | $0 | 36,181 | Sep 16, 2025 |
| Sep 15, 2025 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -325 | $6.43 | $2,090 | 35,856 | Sep 16, 2025 |
| Mar 4, 2025 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -3,445 | $6.29 | $22k | 34,314 | Mar 6, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +5,416 | $0.00 | $0 | 33,176 | Mar 4, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +4,583 | $0.00 | $0 | 37,759 | Mar 4, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +10,833 | $0.00 | $0 | 10,833 | Mar 4, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +9,166 | $0.00 | $0 | 9,166 | Mar 4, 2025 |
| Oct 31, 2024 | CARM Carisma Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative | +38,700 | $0.00 | $0 | 38,700 | Nov 1, 2024 |
| Feb 29, 2024 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common | -21,840 | $1.17 | $26k | 398,618 | Mar 4, 2024 |
| Mar 1, 2024 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common | -5,109 | $1.20 | $6,131 | 393,509 | Mar 4, 2024 |
| Feb 28, 2024 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +198,959 | $0.00 | $0 | 420,458 | Feb 29, 2024 |
| Jan 24, 2024 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +14,167 | $0.00 | $0 | 221,499 | Jan 25, 2024 |
Questions about Sohanya Roshan Cheng
Answered from the filings on this page, as of the latest one.
Is Sohanya Roshan Cheng buying or selling?
In the last 12 months Sohanya Roshan Cheng reported 0 open-market buys worth $0 and 2 open-market sells worth $46k on SEC Form 4; the latest was sold $3,078 of KPTI on May 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Sohanya Roshan Cheng's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sohanya Roshan Cheng has 0.
Where does Sohanya Roshan Cheng file Form 4?
Sohanya Roshan Cheng has filed Form 4 at KPTI (Karyopharm Therapeutics Inc.) as EVP & Chief Commercial Officer; CARM (Carisma Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.